Philadelphia Chromosome-negative B-cell Acute Lymphoblastic Leukemia

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia [Phase 2]

  A Phase 2 trial is evaluating DA-EPOCH chemotherapy with or without rituximab, in combination with tafasitamab, for newly diagnosed Philadel…

• CLINICAL_TRIALS research · 2025-08-06
  Clinical Trial Update: Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 trial evaluating the effectiveness and safety of blinatumomab combined with donor lymphocyte infusion as maintenance therapy after a…

• CLINICAL_TRIALS trial_result · 2024-09-19
  Clinical Trial Update: Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALL [Phase 2]

  A Phase 2 trial evaluating reduced-dose chemotherapy followed by blinatumomab as induction therapy for newly diagnosed Philadelphia-negative…

• CLINICAL_TRIALS trial_result · 2021-04-13
  Clinical Trial Update: Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia [Phase 2]

  Phase 2 study assessing the combination of chemotherapy with inotuzumab ozogamicin in patients with B-cell acute lymphoblastic leukemia, inc…

• CLINICAL_TRIALS research · 2019-02-19
  Clinical Trial Update: Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults

  Update on a multicenter trial evaluating treatment for Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia in young adults;…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.